Kehoe Law Firm, P.C. is investigating securities class action claims on behalf of shareholders of Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA).
WALGREENS INVESTORS WITH FINANCIAL LOSSES ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. FOR A FREE, NO OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.
Investors of Walgreens should be aware that the U.S. Department of Justice (“DOJ”) has filed a civil complaint in federal court alleging that Walgreens Boots Alliance, Walgreen Co. and various subsidiaries dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act (“CSA”) and then sought reimbursement for many of these prescriptions from various federal health care programs in violation the False Claims Act (“FCA”).
According to the complaint, “. . . from approximately August 2012 through the present, Walgreens knowingly filled millions of prescriptions for controlled substances that lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice. Among the millions of unlawful prescriptions that Walgreens allegedly filled were prescriptions for dangerous and excessive quantities of opioids, prescriptions for early refills of opioids and prescriptions for the especially dangerous and abused combination of drugs known as the ‘trinity,’ which is made up of an opioid, a benzodiazepine and a muscle relaxant.”
On this news, the stock price of Walgreens dropped more than 5% after the stock market closed on January 17, 2025.
WALGREENS SHAREHOLDERS INTERESTED IN LEARNING MORE ABOUT THE SECURITIES CLASS ACTION INVESTIGATION CAN ALSO EMAIL [email protected] OR CONTACT EITHER JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected].
SEND US A MESSAGE
Contact Us
ADDRESS
Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103